PortfoliosLab logo
GHRS vs. SEEL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GHRS and SEEL is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

GHRS vs. SEEL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GH Research PLC (GHRS) and Seelos Therapeutics, Inc. (SEEL). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

GHRS:

$746.20M

SEEL:

$214.97K

EPS

GHRS:

-$0.79

SEEL:

$351.04

PS Ratio

GHRS:

0.00

SEEL:

0.11

PB Ratio

GHRS:

2.40

SEEL:

15.10

Total Revenue (TTM)

GHRS:

$0.00

SEEL:

$376.00K

Gross Profit (TTM)

GHRS:

-$78.00K

SEEL:

$361.00K

EBITDA (TTM)

GHRS:

-$41.58M

SEEL:

-$3.12M

Returns By Period


GHRS

YTD

71.86%

1M

11.70%

6M

34.71%

1Y

-14.62%

3Y*

6.28%

5Y*

N/A

10Y*

N/A

SEEL

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


GH Research PLC

Seelos Therapeutics, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GHRS vs. SEEL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GHRS
The Risk-Adjusted Performance Rank of GHRS is 4545
Overall Rank
The Sharpe Ratio Rank of GHRS is 4444
Sharpe Ratio Rank
The Sortino Ratio Rank of GHRS is 5151
Sortino Ratio Rank
The Omega Ratio Rank of GHRS is 4949
Omega Ratio Rank
The Calmar Ratio Rank of GHRS is 3737
Calmar Ratio Rank
The Martin Ratio Rank of GHRS is 4242
Martin Ratio Rank

SEEL
The Risk-Adjusted Performance Rank of SEEL is 88
Overall Rank
The Sharpe Ratio Rank of SEEL is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of SEEL is 00
Sortino Ratio Rank
The Omega Ratio Rank of SEEL is 11
Omega Ratio Rank
The Calmar Ratio Rank of SEEL is 00
Calmar Ratio Rank
The Martin Ratio Rank of SEEL is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GHRS vs. SEEL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for GH Research PLC (GHRS) and Seelos Therapeutics, Inc. (SEEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GHRS vs. SEEL - Dividend Comparison

Neither GHRS nor SEEL has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

GHRS vs. SEEL - Drawdown Comparison


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GHRS vs. SEEL - Volatility Comparison


Loading data...

Financials

GHRS vs. SEEL - Financials Comparison

This section allows you to compare key financial metrics between GH Research PLC and Seelos Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M202120222023202420250
376.00K
(GHRS) Total Revenue
(SEEL) Total Revenue
Values in USD except per share items